Healthcare · Medical Instruments Supplies · NASDAQ
MiniMed Group (MMED) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $4.70B and a free-cash-flow yield of -9.8%. Over the most recent reported fiscal year, revenue grew 14.2%. Nama's AI scorecard rates it Sell, 3.2 out of 10.
AI scorecard
Sell · 3.2/10
Negative, at the mild end of Sell. As of Nov 7, 2026.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-31.6%
How far the last close sits under the highest price of the past five years.
Market cap
$4.70B
Trailing P/E
—
Price / book
1.3
Price / sales
1.5
FCF yield
-9.8%
Dividend yield
—
Gross margin
53.9%
Operating margin
-5.8%
Net margin
-10.3%
Revenue growth (YoY)
+14.2%
Revenue growth (3-yr annual)
+11.4%
EPS growth (YoY)
—
FCF/share growth (YoY)
—
Beta
—
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Instruments Supplies
MMED earnings
Next report: Nov 16, 2026 (Q2 2027, EPS estimate $0.10).
Beat the EPS estimate in 1 of 3 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q1 2027
Sep 1, 2026
$0.13
$0.10
+30.0%
$843.00M
Q4 2026
Jun 3, 2026
-$0.60
-$0.22
-172.7%
$837.00M
Q3 2026
Apr 17, 2026
$0.08
$0.21
-61.9%
$790.00M
MMED analyst price target
Median target $27.00 from 15 analysts, ranging $15.00 – $30.00.
Nama's AI scorecard currently rates MiniMed Group Sell (3.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
When does MMED report earnings?
MiniMed Group's next scheduled report is on Nov 16, 2026. Analysts expect EPS of $0.10.
What is the MMED price target?
The median analyst price target from 15 analysts is $27.00, with a range of $15.00 – $30.00.
Is MMED Shariah compliant?
Nama's AAOIFI-style screen reads MiniMed Group as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.